Ray Co., Ltd. (KOSDAQ:228670)
South Korea
· Delayed Price · Currency is KRW 9,480.00
+630.00 (7.12%)
Apr 29, 2026, 3:30 PM KST
Ray Co., Ltd. Revenue
In the year 2025, Ray Co., Ltd. had annual revenue of 111.32B KRW with 39.43% growth. Ray Co., Ltd. had revenue of 29.02B in the quarter ending December 31, 2025, with 90.15% growth.
Revenue
111.32B
Revenue Growth
+39.43%
P/S Ratio
1.24
Revenue / Employee
625.41M
Employees
178
Market Cap
138.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 111.32B | 31.48B | 39.43% |
| Dec 31, 2024 | 79.84B | -66.04B | -45.27% |
| Dec 31, 2023 | 145.88B | 16.88B | 13.09% |
| Dec 31, 2022 | 129.00B | 38.66B | 42.80% |
| Dec 31, 2021 | 90.34B | 35.13B | 63.64% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Osang Healthcare Co.,Ltd | 128.63B |
| P&S Robotics | 8.55B |
| LabGenomics | 88.16B |
| T&R Biofab | 26.97B |
| DRTECH | 116.30B |
| Sugentech | 9.42B |
| HASS Corp. | 16.59B |
| Gencurix | 3.39B |